Follow-The-Filings

Featured 13F manager

DME Capital Management David Einhorn

New York, NY 20 processed 13Fs on this site · 2021 Q3–2026 Q2

  • $3.9B
  • 46 holds
  • 2026 Q2
  • +22.5% QoQ
  • Top 5 38.2%

David Einhorn files DME Capital Management as a Form 13F. The latest book is 2026 Q2 at $3.9B, up 22.5% QoQ, led by Green Brick Partners, Fluor, and Core Natural Resources.

Portfolio

2026 Q2 · filed 8/14/2026 · 46 long · top 12 shown

top 5 38.2% · top 10 52.8%

AUM over time

2026 Q2 $3.9B +22.5% QoQ
2021 Q3 · $1.5B 2021 Q3 · $1.5B
Q3 2021
2021 Q4 · $1.7B · +17.2% QoQ 2021 Q4 · $1.7B · +17.2% QoQ
Q4
2022 Q1 · $1.6B · −10.0% QoQ 2022 Q1 · $1.6B · −10.0% QoQ
Q1 2022
2022 Q2 · $1.3B · −18.3% QoQ 2022 Q2 · $1.3B · −18.3% QoQ
Q2
2022 Q3 · $1.4B · +9.8% QoQ 2022 Q3 · $1.4B · +9.8% QoQ
Q3
2022 Q4 · $1.4B · +2.3% QoQ 2022 Q4 · $1.4B · +2.3% QoQ
Q4
2023 Q1 · $1.8B · +27.4% QoQ 2023 Q1 · $1.8B · +27.4% QoQ
Q1 2023
2023 Q2 · $2.1B · +15.9% QoQ 2023 Q2 · $2.1B · +15.9% QoQ
Q2
2023 Q3 · $1.8B · −17.4% QoQ 2023 Q3 · $1.8B · −17.4% QoQ
Q3
2023 Q4 · $2B · +16.3% QoQ 2023 Q4 · $2B · +16.3% QoQ
Q4
2024 Q1 · $2.2B 2024 Q1 · $2.2B
Q1 2024
2024 Q2 · $2B · −6.5% QoQ 2024 Q2 · $2B · −6.5% QoQ
Q2
2024 Q3 · $2.4B · +17.6% QoQ 2024 Q3 · $2.4B · +17.6% QoQ
Q3
2024 Q4 · $1.9B · −19.1% QoQ 2024 Q4 · $1.9B · −19.1% QoQ
Q4
2025 Q1 · $2B · +1.5% QoQ 2025 Q1 · $2B · +1.5% QoQ
Q1 2025
2025 Q2 · $2.3B · +17.8% QoQ 2025 Q2 · $2.3B · +17.8% QoQ
Q2
2025 Q3 · $2.5B · +9.3% QoQ 2025 Q3 · $2.5B · +9.3% QoQ
Q3
2025 Q4 · $2.8B · +12.1% QoQ 2025 Q4 · $2.8B · +12.1% QoQ
Q4
2026 Q1 · $3.2B · +12.0% QoQ 2026 Q1 · $3.2B · +12.0% QoQ
Q1 2026
2026 Q2 · $3.9B · +22.5% QoQ 2026 Q2 · $3.9B · +22.5% QoQ
Q2

Book

2025 Q4 2025 Q3 · filed 17 Feb · long equity

GRBK - Green Brick Partners 20.82% Hold 9,467,383 $62.66 $593M — —
FLR - Fluor 7.73% Add +0.8% 5,555,900 $39.63 $220M +42,220 −$12M
CNR - Core Natural Resources 6.52%, was 7.08% Reduce −2.6% 2,100,480 $88.51 $186M −55,160 +$6M
BHF - Brighthouse Finl 6.35% Hold 2,792,100 $64.79 $181M — —
PKG - Graphic Packaging 4.45%, was 3.62% Add +78.8% 8,415,110 $15.06 $127M +3,709,160 +$35M
PCG - Pg And E 4.39%, was 3.79% Add +22.0% 7,784,103 $16.07 $125M +1,403,250 +$29M
CPRI - Capri 4.08%, was 2.11% Add +77.4% 4,768,007 $24.40 $116M +2,080,410 +$63M
CNC - Centene Del 3.81%, was 2.19% Add +69.1% 2,639,420 $41.15 $109M +1,078,880 +$53M
KD - Kyndryl 3.56%, was 5.13% Reduce −12.1% 3,816,353 $26.56 $101M −527,274 −$29M
TEVA - Teva Pharmaceutical Inds 3.35% Reduce −19.1% 3,058,734 $31.21 $95M −720,043 +$19M
VSXY - Victorias Secret And 3.30% Reduce −10.1% 1,737,869 $54.17 $94M −194,593 +$42M
DHT — 3.16%, was 3.58% Reduce −3.3% 7,366,664 $12.21 $90M −254,270 −$1M
PENN - Penn Entertainment 3.13%, was 5.13% Reduce −10.7% 6,044,440 $14.75 $89M −725,000 −$41M
GLD - Spdr Gold Tr 2.37%, was 2.45% Reduce −2.6% 170,561 $396.31 $68M −4,540 +$5M
ACHC — 2.05%, was 1.60% Add +150.9% 4,121,203 $14.19 $58M +2,478,493 +$18M
WFRD - Weatherford Intl 2.04%, was 2.59% Reduce −22.6% 743,620 $78.26 $58M −217,190 −$8M
LBTYA - Liberty Global · CL A 1.96%, was 2.35% Reduce −4.1% 5,004,432 $11.14 $56M −216,070 −$4M
CNH - Cnh Indl 1.87%, was 2.52% Reduce −2.3% 5,767,540 $9.22 $53M −136,920 −$11M
ROIV - Roivant Sciences 1.58% Reduce −9.1% 2,069,309 $21.70 $45M −206,220 +$10M
WBD - Warner Bros Discovery 1.55% New 1,533,080 $28.82 $44M +1,533,080 +$44M
SPB — 1.38% New 663,890 $59.08 $39M +663,890 +$39M
HSIC - Henry Schein 1.24% New 469,250 $75.58 $35M +469,250 +$35M
GPN - Global Pmts 1.23% New 452,730 $77.40 $35M +452,730 +$35M
BKV — 1.23% New 1,287,943 $27.15 $35M +1,287,943 +$35M
AR - Antero Resources 1.23% New 1,014,070 $34.46 $35M +1,014,070 +$35M
DECK - Deckers Outdoor 1.09% New 298,778 $103.67 $31M +298,778 +$31M
CI - The Cigna Group 0.91% Hold 93,750 $275.23 $26M — —
SLDE - Slide Ins 0.79% New 1,149,880 $19.48 $22M +1,149,880 +$22M
United Parks & Resorts 0.73% Add +22.0% 574,620 $36.30 $21M +103,570 −$3M
LKFT - Galapagos 0.55% Hold 482,746 $32.70 $16M — —
COYA - Coya Therapeutics 0.41%, was 0.37% Add +23.0% 2,025,940 $5.80 $12M +379,500 +$2M
SNX - Td Synnex 0.30%, was 0.25% Add +44.7% 56,490 $150.23 $8M +17,460 +$2M
SHC - Sotera Health 0.29%, was 0.11% Add +155.4% 461,270 $17.64 $8M +280,690 +$5M
GDX - Vaneck ETF Trust 0.20%, was 0.23% Reduce −15.0% 64,960 $85.77 $6M −11,500 −$270K
KWEB - Kraneshares Trust 0.16%, was 0.14% Add +52.3% 131,510 $34.05 $4M +45,140 +$850K
GPRO - Gopro · CL A 0.08% Hold 1,693,860 $1.41 $2M — —
GANX - Gain Therapeutics 0.06% Hold 566,130 $3.22 $2M — —
PTON - Peloton Interactive · CL A 0.05% Hold 246,460 $6.16 $2M — —
NUVB - Nuvation Bio · CL A 0.01% Hold 34,995 $8.96 $314K — —

Exits / last held

Not current holdings · last reported size, unchanged · gone vs 2025 Q3

Stock % of portfolio Recent activity Shares Reported price* Value Share change $ change
SDRL - Seadrill 1.89% Exit 0 $30.21 $48M −1,588,828 −$48M
Nexstar Media Group 0.58% Exit 0 $197.74 $15M −73,940 −$15M
HPQ - HP 0.32% Exit 0 $27.23 $8M −300,000 −$8M
OIH - Vaneck ETF Trust 0.13% Exit 0 $259.87 $3M −12,360 −$3M

Weight bar: held both quarters added sold at this quarter’s reported price

* Reported price is value ÷ shares from the 13F as of period end — not a live market quote. Weight % is each long-equity position ÷ full 13F AUM, so rows may not sum to 100% when the filing includes options or other non-equity (excluded from this table). Share change and $ change are vs 2025 Q3. Click column headers to sort · click New / Hold / Add / Reduce to promote that move type to the top. Exit opens the last-held block below.

Filings history

20 periods · normalized AUM · open a period for holdings

Period Holds AUM QoQ Form Filed Filing ID
2026 Q2 46 $3.9B +22.5% 13F-HR 8/14/2026 000117266126003786
2026 Q1 45 $3.2B +12.0% 13F-HR 5/15/2026 000117266126002341
2025 Q4 41 $2.8B +12.1% 13F-HR 2/17/2026 000117266126001122
2025 Q3 37 $2.5B +9.3% 13F-HR 11/14/2025 000117266125005032
2025 Q2 34 $2.3B +17.8% 13F-HR 8/14/2025 000117266125003351
2025 Q1 33 $2B +1.5% 13F-HR 5/15/2025 000117266125002307
2024 Q4 36 $1.9B −19.1% 13F-HR 2/14/2025 000117266125001165
2024 Q3 38 $2.4B +17.6% 13F-HR 11/14/2024 000117266124005240
2024 Q2 39 $2B −6.5% 13F-HR 8/14/2024 000117266124003549
2024 Q1 42 $2.2B — 13F-HR 5/15/2024 000117266124002489
2023 Q4 40 $2B +16.3% 13F-HR 2/14/2024 000117266124001512
2023 Q3 39 $1.8B −17.4% 13F-HR 11/14/2023 000117266123004012
2023 Q2 41 $2.1B +15.9% 13F-HR 8/14/2023 000117266123003174
2023 Q1 39 $1.8B +27.4% 13F-HR 5/15/2023 000117266123002282
2022 Q4 42 $1.4B +2.3% 13F-HR 2/14/2023 000117266123001336
2022 Q3 42 $1.4B +9.8% 13F-HR 11/14/2022 000117266122002565
2022 Q2 47 $1.3B −18.3% 13F-HR 8/15/2022 000117266122002019
2022 Q1 52 $1.6B −10.0% 13F-HR 5/16/2022 000117266122001474
2021 Q4 57 $1.7B +17.2% 13F-HR 2/14/2022 000117266122000884
2021 Q3 58 $1.5B — 13F-HR 11/15/2021 000117266121002370

About

DME Capital Management

20 processed 13Fs on this site · 2021 Q3–2026 Q2

Entity
DME Capital Management
Notable person
David Einhorn
SEC filing name
DME Capital Management, LP
Location
New York, NY
All SEC filings
View on sec.gov